Literature DB >> 2953150

Cellular immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets.

R J Dattwyler, J A Thomas, J L Benach, M G Golightly.   

Abstract

Although some manifestations of Lyme disease may be secondary to the presence of B. burgdorferi, the immune system appears to play a significant role in the clinical manifestations of the disease. The humoral response is well characterized, however the cellular response remains poorly defined. To further define cellular immunity in Lyme disease, the responses of lymphocytes from patients with active Lyme disease were assessed to Con a, PHA, PWM, tetanus toxoid, and whole live B. burgdorferi. In addition, the natural killer cell (NK) function of these patients was assayed. As compared to the controls the lymphocyte response to Con A was reduced and the response to PHA was increased. There was a significant proliferative response to B. burgdorferi in all patients with no response in the controls. The responses to PWM and tetanus toxoid were not different in the two groups. NK cell function in the patients with active disease was reduced as compared to the normal controls and patient's who were not clinically active. We conclude that there is a significant alteration in cellular immunity in active LD consistent with a defect in the induction of suppressor cells leading to a vigorous humoral response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2953150     DOI: 10.1016/s0176-6724(86)80118-3

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  11 in total

1.  Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys.

Authors:  G H Giambartolomei; V A Dennis; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 2.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

3.  Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.

Authors:  M L Mbow; N Zeidner; R D Gilmore; M Dolan; J Piesman; R G Titus
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease.

Authors:  A Vaz; L Glickstein; J A Field; G McHugh; V K Sikand; N Damle; A C Steere
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation.

Authors:  M S de Souza; A L Smith; D S Beck; L J Kim; G M Hansen; S W Barthold
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.

Authors:  A Krause; G R Burmester; A Rensing; C Schoerner; U E Schaible; M M Simon; P Herzer; M D Kramer; R Wallich
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse.

Authors:  M S de Souza; A L Smith; D S Beck; G A Terwilliger; E Fikrig; S W Barthold
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology.

Authors:  H W Horowitz; C S Pavia; S Bittker; G Forseter; D Cooper; R B Nadelman; D Byrne; R C Johnson; G P Wormser
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

10.  High-dose intravenous penicillin G does not prevent further progression in early neurological manifestation of Lyme borreliosis.

Authors:  J Kohler; H Schneider; A Vogt
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.